"Le CHU demande aux usagers de présenter à l’entrée de ses sites hospitaliers un « pass sanitaire », pour accéder au CHU. Ces consignes ne s’appliquent pas : - aux urgences adultes, pédiatriques, gynécoobstétriques, odontologiques et ophtalmologiques ; Plus d'infos sur le site internet du CHU"

During the past decade, Chu Estaing; Dermatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chu Estaing; Dermatologie" are "Basal Cell Carcinoma" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Chu Estaing; Dermatologie" in a lesser frequency.

Most popular intervention types in "Chu Estaing; Dermatologie" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cobimetinib" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chu Estaing; Dermatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chu Estaing; Dermatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chu Estaing; Dermatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chu Estaing; Dermatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".